During induction, BMP6 treatment resulted in up-regulation of all four hypertrophic and osteogenic markers (Col10a1, ALP, Runx2, Col1a1) at 4 weeks and three of four hypertrophic/osteogenic markers at 6 weeks when compared to control OM treatment (Fig. 8). Here, BMP6 is linked to ocular melanoma.